(Q48088615)

8 February 2018

title

Feasibility of IA thrombolysis for acute ischemic stroke among anticoagulated patients (English)

1 reference

8 February 2018

1 reference

Nazli Janjua

1

1 reference

8 February 2018

Ammar Alkawi

2

1 reference

8 February 2018

Alexandros Georgiadis

3

1 reference

8 February 2018

M Fareed K Suri

4

1 reference

8 February 2018

M Salim Ibrahim

5

1 reference

8 February 2018

Jawad F Kirmani

6

1 reference

8 February 2018

Adnan I Qureshi

7

1 reference

8 February 2018

publication date

1 January 2007

1 reference

8 February 2018

published in

Neurocritical Care

1 reference

8 February 2018

volume

7

1 reference

8 February 2018

issue

2

1 reference

8 February 2018

page(s)

152-155

1 reference

8 February 2018

https://scigraph.springernature.com/pub.10.1007/s12028-007-0027-7

exact match

0 references

cites work

Guidelines for thrombolytic therapy for acute stroke: a supplement to the guidelines for the management of patients with acute ischemic stroke. A statement for healthcare professionals from a Special Writing Group of the Stroke Council, American Hea

1 reference

https://api.crossref.org/works/10.1007%2FS12028-007-0027-7

PROACT: a phase II randomized trial of recombinant pro-urokinase by direct arterial delivery in acute middle cerebral artery stroke. PROACT Investigators. Prolyse in Acute Cerebral Thromboembolism.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12028-007-0027-7

Cerebral hemorrhage after intra-arterial thrombolysis for ischemic stroke: the PROACT II trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12028-007-0027-7

Risk factors for severe hemorrhagic transformation in ischemic stroke patients treated with recombinant tissue plasminogen activator: a secondary analysis of the European-Australasian Acute Stroke Study (ECASS II)

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12028-007-0027-7

Thrombolysis (different doses, routes of administration and agents) for acute ischaemic stroke

21 January 2018

1 reference

12 December 2020

Treatment of warfarin-associated coagulopathy: a physician survey

1 reference

12 December 2020

Tissue plasminogen activator for acute ischemic stroke

1 reference

12 December 2020

Intra-arterial prourokinase for acute ischemic stroke. The PROACT II study: a randomized controlled trial. Prolyse in Acute Cerebral Thromboembolism.

1 reference

12 December 2020

Middle cerebral arterial thrombosis in a patient with hypofibrinogenemia, 5 days after rFVIIa and FFP infusion.

1 reference

12 December 2020

Impaired warfarin response secondary to high-dose vitamin K1 for rapid anticoagulation reversal: case series and literature review

1 reference

12 December 2020

Measurements of acute cerebral infarction: a clinical examination scale

1 reference

12 December 2020

10.1007/S12028-007-0027-7

Identifiers

DOI

1 reference

8 February 2018

1 reference

8 February 2018